Intracavitary bleomycin vs interferon in the management of malignant pleural effusions.
Sartori
S
S
Trevisani
L
L
Nielsen
I
I
Tassinari
D
D
Abbasciano
V
V
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007322:Instillation, Drug; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D011994:Recombinant Proteins; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012597:Sclerosing Solutions; D001761:Bleomycin